CBD at the crossroads: a response to the FSA guidelines
Professor Mike Barnes responds to the Food Standard Agency's guidelines regarding CBD products in Health Europa this week.
"As a result of demand and product innovation, the CBD industry is reportedly set to be worth an impressive £1bn by 2025, surpassing sales of popular supplements such as vitamin C and D.
Until now, CBD has been in a period of regulatory uncertainty and the industry faced understandable criticism when high profile cannabis probes found that over half of the most popular CBD oils did not contain the amount of CBD promised on the label.
On 13 February 2020, the Food Standards Agency(FSA) announced a deadline of 31 March 2021 for the submission of a valid application for novel food authorisation for businesses selling food and food supplements containing CBD in the UK."
Read the full article at Health Europa.